Abstract
The Coca-Cola Company will report fiscal second-quarter 2026 results on July 28, 2026 Pre-MKt; this preview synthesizes recent financials, company guidance signals, and institutional expectations to frame what matters for revenue, margins, and earnings trajectory.Market Forecast
Consensus and company-tracked forecasts point to second-quarter 2026 revenue of 13.16 billion US dollars, up 4.94% year over year, EBIT of 4.59 billion US dollars, up 10.25% year over year, and adjusted EPS of 0.93, up 12.13% year over year. External previews indicate organic revenue likely rising around the mid‑3% range with an EPS outcome around 0.94, modestly above the prevailing consensus.Momentum in the core portfolio remains anchored by pack-price architecture and stable volume trends evidenced in the prior quarter’s update; price/mix remains positive and underpins mid-single-digit top-line growth expectations into this print. The concentrates business stands out as the near-term growth engine, supported by last quarter revenue of 7.39 billion US dollars and an 8% year-over-year increase in concentrate sales volume.
Last Quarter Review
In the previous quarter (fiscal Q1 2026), The Coca-Cola Company delivered revenue of 12.47 billion US dollars (up 11.19% year over year), a gross profit margin of 62.96%, GAAP net profit attributable to shareholders of 3.92 billion US dollars, a net profit margin of 31.46%, and adjusted EPS of 0.86 (up 17.81% year over year).A notable financial highlight was EBIT of 4.30 billion US dollars, up 13.55% year over year, reflecting solid operating leverage. Main business performance featured concentrates revenue of 7.39 billion US dollars and finished products revenue of 5.09 billion US dollars, with concentrate sales volume up 8% year over year and worldwide unit case volume up 3% year over year.
Current Quarter Outlook
Main business drivers
Across the core portfolio, second-quarter expectations rest on continued positive price/mix and resilient consumption patterns that supported the prior quarter’s double-digit revenue growth. The company’s pack and package architecture is designed to serve both value-seeking and premium-seeking consumers, which helped drive stable unit case trends last quarter and is expected to carry into this quarter’s results. Against that backdrop, mid-single-digit reported revenue growth is projected, and operating efficiency could maintain healthy flow-through, even as gross margin guidance is not explicitly quantified ahead of the print.Within North America and key international markets, elasticity has remained manageable in recent updates, aided by disciplined revenue growth management rather than broad-based discounting. Last quarter’s performance showed price/structure gains while concentrate sales outpaced unit cases, a pattern that typically supports consolidated gross margin stability. With summer seasonality underway, retail activation, sports partnerships, and innovation on premium hydration and zero-sugar extensions should keep shelf visibility high, which historically aids mix in the second quarter.
On profitability, the combination of pricing carryover, marketing efficiency, and normalized supply chain costs is expected to keep EBIT growing ahead of the top line. Forecasts indicate EBIT growth above 10% year over year for this quarter, outpacing revenue growth and implying incremental margin support from mix and costs. While the company has not pre-disclosed a gross margin target for the quarter, the prior quarter’s 62.96% gross margin and 31.46% net margin provide a strong baseline for comparison.
Most promising business
The concentrates franchise is the focal point for near-term upside. Last quarter’s concentrates revenue of 7.39 billion US dollars, alongside an 8% year-over-year increase in concentrate sales volume, underscored demand durability and pricing power that typically translate to outsized margin contribution. Concentrates economics generally benefit from structurally higher margin characteristics and more direct pricing control compared with finished goods.Into the second quarter, this dynamic can help offset any localized softness in certain channels by supporting average realized revenue per case. Positive price/mix should remain evident, complemented by targeted innovation and disciplined commercial execution across priority geographies. Additionally, company indications for the full year suggest currency may provide a modest tailwind to net operating revenue and operating income, which could further amplify concentrates’ reported growth in the near term.
Factors likely to move the stock
Earnings versus expectations will be the central catalyst. Forecasts tracked ahead of the print suggest EPS of roughly 0.93–0.94, with organic revenue growth clustered in the mid‑3% range; a modest beat on either metric could be enough to sustain recent share gains. Revenue mix will matter: if concentrate sales once again outpace unit case growth, investors may infer continued margin resilience, a setup that leans constructive for EBIT and EPS.Guidance cadence will also be closely watched. The company previously raised its comparable EPS growth outlook for the full year to the high-single-digit range; affirmation toward the upper end would support the consensus tilt. Commentary on pricing elasticity, promotional intensity during peak summer, and any update on marketing investment phasing could recalibrate expectations around second-half growth and margin flow-through.
A recent development to monitor is the ransomware incident affecting the Fairlife business system, which led to a temporary suspension of production in the United States in mid-July. While the timing places this disruption in the third quarter rather than the second, any management commentary on expected duration, recovery plans, and potential volume or revenue impact for the early part of the third quarter could influence near-term sentiment and how investors frame the second-half outlook. Finally, ongoing portfolio initiatives, including steps toward an eventual IPO of the Indian bottling business in 2027, reinforce the broader strategic emphasis on focusing resources around brand stewardship and higher-return concentrate economics, a narrative likely to be revisited in management’s discussion.
Analyst Opinions
Recent institutional commentary is predominantly bullish, with buy ratings and constructive previews outweighing neutral views by an estimated ratio of roughly 8 to 1 over the last several weeks. UBS anticipates a solid second quarter, looking for EPS near 0.94 (slightly above the prevailing consensus) and organic revenue growth around 3.6%, and suggests the company could track toward the upper end of its full-year targets for organic sales growth of 4%–5% and comparable EPS growth of 8%–9%. Morgan Stanley reiterates a positive stance, highlighting that the ongoing ramp of value-added dairy and premium hydration helps sustain outperformance and supports out-year organic sales growth. RBC Capital continues with Buy ratings and an 87.00 US dollars price target, pointing to effective revenue growth management and an ability to weather external shocks. J.P. Morgan remains constructive with an 83.00 US dollars target, while Citi maintains a Buy and recently adjusted its target to 97.00 US dollars, citing confidence in execution. Barclays and Wells Fargo also reiterate Buy ratings with targets clustered in the low‑to‑mid 80s and high 80s. Deutsche Bank recently nudged its target to 92.00 US dollars and remains positive.In aggregate, the majority view expects a mid-single-digit top-line advance this quarter with better‑than‑top‑line EBIT growth and a high-single-digit to low‑double‑digit comparable EPS increase. Analysts focus on sustained price/mix benefits in concentrates, stable unit case trends, and cost normalization that collectively support operating margin momentum. The key swing factors they highlight are the cadence of organic revenue growth versus price/mix normalization, the degree of margin leverage that can be retained into the second half, and management’s commentary on the Fairlife disruption and summer promotional patterns. As long as the company delivers near the 13.16 billion US dollars revenue and approximately 0.93–0.94 EPS markers with steady mix-driven profitability, the bullish camp expects guidance to remain intact and lean toward the upper end for the year, reinforcing the favorable setup into the seasonally important summer period.
Comments